TNGX EBITDA
Tango Therapeutics Inc · EBITDA
TNGX EBITDA
Latest reported-$121.86Mperiod ending
TNGX EBITDA (-$14.52M → -$121.86M)
Annual EBITDA
High-resolution chart · PNG
TNGX ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -99,309,000 | |
| -127,595,000 | |
| -99,195,000 | |
| -106,514,000 | |
| -57,046,000 | |
| -51,254,000 | |
| -14,519,000 |